In summary, our study reveals that exogenous supplement of TGF-β1 protects against LPC-induced cognitive deficit and demyelinating lesion in modeling mice, through suppressing proinflammatory microglial pyroposis via NF-κB/ERK1/2 signal pathways. Here, MAPK3 is linked to Cognitive impairment.